Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Wienke

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Genetic Counseling|August 13, 2013
Alpha-1 couples: interpersonal and intrapersonal predictors of spousal communication and stressRachel A Smith, Sara Wienke, Donna L Coffman
Journal of Community Genetics|September 25, 2013
Expanded carrier screening panels-does bigger mean better?Sara Wienke, Kimberly Brown, Meagan Farmer, et al.
Clinical Lung Cancer|August 12, 2022
Oncogene Overlap Analysis of Circulating Cell-free Tumor DNA to Explore the Appropriate Criteria for Defining MET Copy Number-Driven Lung CancerDavid C C Tsui, Leylah M Drusbosky, Sara Wienke, et al.
JCO Precision Oncology|October 30, 2025
Variability of Circulating Tumor DNA Levels in Plasma Samples From Patients With Advanced Non-Small-Cell Lung Cancer in the Absence of TreatmentAleksandra Markovets, Diana Merino Vega, Chris Abbosh, et al.
The Nursing Clinics of North America|December 4, 2013
Genetics' influence on patient experiences with a rare chronic disorder: a photovoice study of living with alpha-1 antitrypsin deficiencyPamela Holtzclaw Williams, Lucinda Shore, Marvin Sineath, et al.
The Journal of Molecular Diagnostics : JMD|January 29, 2025
Analytical and Clinical Validation of the Plasma-Based Guardant360 CDx Test for Assessing HER2 (ERBB2) Mutation Status in Patients with Non-Small-Cell Lung Cancer for Treatment with Trastuzumab Deruxtecan in DESTINY-Lung01/02Zhenhao Qi, Shinya Tokuhiro, Justin I Odegaard, et al.
Cancer Research Communications|July 29, 2025
Methylation-Based ctDNA Tumor Fraction Changes Predict Long-Term Clinical Benefit From Immune Checkpoint Inhibitors in RADIOHEAD, a Real-World Pan-Cancer StudySamantha I Liang, Zoe Quandt, Sara Wienke, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Genetic Counseling|August 13, 2013
Alpha-1 couples: interpersonal and intrapersonal predictors of spousal communication and stressRachel A Smith, Sara Wienke, Donna L Coffman
Journal of Community Genetics|September 25, 2013
Expanded carrier screening panels-does bigger mean better?Sara Wienke, Kimberly Brown, Meagan Farmer, et al.
Clinical Lung Cancer|August 12, 2022
Oncogene Overlap Analysis of Circulating Cell-free Tumor DNA to Explore the Appropriate Criteria for Defining MET Copy Number-Driven Lung CancerDavid C C Tsui, Leylah M Drusbosky, Sara Wienke, et al.
JCO Precision Oncology|October 30, 2025
Variability of Circulating Tumor DNA Levels in Plasma Samples From Patients With Advanced Non-Small-Cell Lung Cancer in the Absence of TreatmentAleksandra Markovets, Diana Merino Vega, Chris Abbosh, et al.
The Nursing Clinics of North America|December 4, 2013
Genetics' influence on patient experiences with a rare chronic disorder: a photovoice study of living with alpha-1 antitrypsin deficiencyPamela Holtzclaw Williams, Lucinda Shore, Marvin Sineath, et al.
The Journal of Molecular Diagnostics : JMD|January 29, 2025
Analytical and Clinical Validation of the Plasma-Based Guardant360 CDx Test for Assessing HER2 (ERBB2) Mutation Status in Patients with Non-Small-Cell Lung Cancer for Treatment with Trastuzumab Deruxtecan in DESTINY-Lung01/02Zhenhao Qi, Shinya Tokuhiro, Justin I Odegaard, et al.
Cancer Research Communications|July 29, 2025
Methylation-Based ctDNA Tumor Fraction Changes Predict Long-Term Clinical Benefit From Immune Checkpoint Inhibitors in RADIOHEAD, a Real-World Pan-Cancer StudySamantha I Liang, Zoe Quandt, Sara Wienke, et al.
Pageof 1